| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Maravai Lifesciences Holdings, Inc.
13G/A
MRVI · 56600D107
|
2.5% |
8/13/2026
Event 6/30/2026
|
||||
| Hudson View Holdings LLC | 0.5% | |||||
| Hudson View Capital LLC | 0.5% | |||||
| JD Squared Holdings II LLC | 2.0% | |||||
| JD Squared Capital II LLC | 2.0% | |||||
| Stuart Feldman | 2.5% | |||||
| Matthew Barkoff | 0.2% | |||||
| Joshua Wool | <0.1% | |||||
|
Mural Oncology plc
13G
MURA · G63365103
|
4.4% |
5/14/2025
Event 4/16/2025
|
||||
| Hudson View Holdings LLC | 4.4% | |||||
| Hudson View Capital LLC | 4.4% | |||||
| Stuart Feldman | 4.4% | |||||
| Matthew Barkoff | 1.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.